Flecainide acetate in the prevention of paroxysmal atrial fibrillation: A nine-month follow-up of more than 500 patients
- 20 August 1992
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 70 (5) , A44-A49
- https://doi.org/10.1016/0002-9149(92)91077-h
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials.Circulation, 1990
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- Flecainide acetate for conversion of acute supraventricular tachycardia to sinus rhythmThe American Journal of Cardiology, 1987
- Flecainide versus quinidine for conversion of atrial fibrillation to sinus rhythmThe American Journal of Cardiology, 1986
- Incidence and clinical features of the quinidine-associated long QT syndrome: Implications for patient careAmerican Heart Journal, 1986
- Evaluation of flecainide acetate in rapid atrial fibrillation complicating wolff‐parkinson‐white syndromeClinical Cardiology, 1985
- Effect of Intravenous Flecainide on Atrial Vulnerability in ManDrugs, 1985
- Antiarrhythmic Drugs: a Possible Cause of Out-of-Hospital Cardiac ArrestNew England Journal of Medicine, 1983
- Antiarrhythmic effects of flecainideClinical Pharmacology & Therapeutics, 1980
- FACTORS INFLUENCING PERSISTENCE OF SINUS RHYTHM AFTER DC SHOCK TREATMENT OF ATRIAL FIBRILLATIONActa Medica Scandinavica, 1971